Objective:To investigate the effect of“72-hour proactive follow-up”led by respiratory specialist nurses on reducing the 30-day readmission rate in patients with acute exacerbation of chronic obstructive pulmonary di...Objective:To investigate the effect of“72-hour proactive follow-up”led by respiratory specialist nurses on reducing the 30-day readmission rate in patients with acute exacerbation of chronic obstructive pulmonary disease(COPD)after hospital discharge.Methods:A randomized controlled trial was conducted involving 60 patients with acute exacerbation of COPD admitted from September 2024 to September 2025.The participants were divided into a control group and an observation group,with 30 individuals in each group.The control group received routine discharge guidance nursing measures,including instructions on medication use,key points for condition monitoring,and scheduling of follow-up appointments.The observation group implemented“72-hour proactive follow-up”nursing measures,which included telephone follow-up within 72 hours after discharge,quantitative assessment of respiratory symptoms,dynamic adjustment of medication regimens,and personalized health education.The 30-day readmission rate,mMRC dyspnea index,CAT quality of life score,and other parameters were compared between the two groups.Results:The 30-day readmission rate in the observation group was significantly lower than that in the control group(p<0.05).The mMRC dyspnea index(1.8±0.5)in the observation group was significantly lower than that in the control group(2.5±0.7)(p<0.05).The CAT quality of life score(18.2±3.1)in the observation group was significantly higher than that in the control group(22.4±4.2)(p<0.05).The patient satisfaction score(92.5±4.3)in the observation group was higher than that in the control group(85.6±5.8)(p<0.05).Conclusion:The“72-hour proactive follow-up”nursing intervention demonstrates a favorable effect in reducing readmission rates,exhibiting significant clinical practical value.It can optimize the allocation of medical resources,effectively enhance patients’self-management efficacy,and holds prominent value for clinical promotion and application.展开更多
文摘Objective:To investigate the effect of“72-hour proactive follow-up”led by respiratory specialist nurses on reducing the 30-day readmission rate in patients with acute exacerbation of chronic obstructive pulmonary disease(COPD)after hospital discharge.Methods:A randomized controlled trial was conducted involving 60 patients with acute exacerbation of COPD admitted from September 2024 to September 2025.The participants were divided into a control group and an observation group,with 30 individuals in each group.The control group received routine discharge guidance nursing measures,including instructions on medication use,key points for condition monitoring,and scheduling of follow-up appointments.The observation group implemented“72-hour proactive follow-up”nursing measures,which included telephone follow-up within 72 hours after discharge,quantitative assessment of respiratory symptoms,dynamic adjustment of medication regimens,and personalized health education.The 30-day readmission rate,mMRC dyspnea index,CAT quality of life score,and other parameters were compared between the two groups.Results:The 30-day readmission rate in the observation group was significantly lower than that in the control group(p<0.05).The mMRC dyspnea index(1.8±0.5)in the observation group was significantly lower than that in the control group(2.5±0.7)(p<0.05).The CAT quality of life score(18.2±3.1)in the observation group was significantly higher than that in the control group(22.4±4.2)(p<0.05).The patient satisfaction score(92.5±4.3)in the observation group was higher than that in the control group(85.6±5.8)(p<0.05).Conclusion:The“72-hour proactive follow-up”nursing intervention demonstrates a favorable effect in reducing readmission rates,exhibiting significant clinical practical value.It can optimize the allocation of medical resources,effectively enhance patients’self-management efficacy,and holds prominent value for clinical promotion and application.